Guillermo Villacampa presents the HER2DX assay and its impact on survival outcomes

ESMO shared on LinkedIn:

“For ESMO members: Breaking Science in breast cancer. Guillermo Villacampa presents the HER2DX assay and its impact on survival outcomes.

Discover this video and more in the series on OncologyPRO now.”